Exercise, mitochondrial function, and fatty acid oxidation in fatty liver disease
Exercise, mitochondrial function, and fatty acid oxidation in fatty liver disease
批准号:
7697934
负责人:
RANDY SCOTT RECTOR
金额:
$4.1万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-09-17 至 2010-06-30
关键词:
AdultAffectAmericanBiochemicalBiogenesisBiologicalChronicDefectDevelopmentDiseaseEffectivenessEnvironmentEuglycemic ClampingExerciseExhibitsFatty AcidsFatty LiverFatty acid glycerol estersFree Radical ScavengingFunctional disorderGene ProteinsGlucoseGlucose ClampGoalsHepaticHepatocyteHomeostasisImpairmentIncidenceIndividualInjuryInsulin ResistanceLaboratoriesLeadLinkLipid PeroxidationLipidsLiverLiver MitochondriaLiver diseasesMeasuresMitochondriaModelingMolecularMouse ProteinMultienzyme ComplexesMusObesityOrganellesOxidative StressPathway interactionsPhysical activityPlayPopulationPrevalenceProcessProductionProteinsReactive Oxygen SpeciesReduced GlutathioneRelative (related person)ReportingRodent ModelRoleRunningSeveritiesSystemTestingTherapeuticTrainingTransgenic ModelVery Light ExerciseWorkfatty acid oxidationfeedingfitnessimprovedinsulin sensitivityinsulin signalinglong chain fatty acidmitochondrial dysfunctionnon-alcoholic fatty liveroxidationperoxisomepreventprotein expressionpublic health relevanceresearch studysedentarytherapeutic targettrafficking
中文摘要
描述(由申请人提供):非酒精性脂肪性肝病(NAFLD)估计影响1/3的美国成年人。在这种高脂肪环境中,肝线粒体和过氧化物酶体被认为协同工作以防止脂质积累;然而,过氧化物酶体活性的增强会产生活性氧(ROS),并可能对肝细胞产生破坏性影响。运动被认为是治疗NAFLD的最佳方法之一,但其益处的分子解释却很少。我们开发了一种线粒体三功能蛋白(催化β -氧化的最后三个步骤)杂合小鼠(MTPa),由于线粒体脂肪酸氧化损伤和长链脂肪酸代谢物的积累而产生NAFLD和胰岛素抵抗。该建议的中心假设是,日常运动增加了MTPa小鼠的肝脏线粒体生物生成,导致线粒体脂肪酸氧化能力增加,通过过氧化物酶体途径减少脂肪酸运输,最终减少肝脏氧化应激、脂肪变性和肝损伤。我们还假设肝脏氧化应激的减少将改善肝脏胰岛素信号传导和全身胰岛素敏感性。MTP小鼠和MTP小鼠要么自愿在跑步轮上锻炼,要么静坐6个月。评估肝线粒体生物发生、过氧化物酶体增殖和脂肪酸氧化能力,以及肝脂质过氧化和氧化应激。MTP小鼠还将接受高胰岛素-正糖钳夹,以评估运动对肝脏胰岛素信号传导和全身胰岛素敏感性的影响。该项目的长期目标是探索运动训练与降低肝脂肪变性严重程度相关的机制。公共卫生相关性:据估计,超过1000万美国人患有线粒体脂肪酸氧化障碍,9000万美国成年人患有NAFLD。不幸的是,目前治疗的有效性和生物学机制在很大程度上是未知的。本项目的重点是确定运动通过增加肝脏线粒体功能、减轻肝损伤和改善肝脏胰岛素敏感性来降低NAFLD发病率的潜在机制和治疗靶点。
英文摘要
DESCRIPTION (provided by applicant): Nonalcoholic fatty liver disease (NAFLD) is estimated to affect 1/3 of the US adult population. In this high-fat environment, hepatic mitochondria and peroxisomes are thought to work in concert to prevent lipid accumulation; however, enhanced peroxisomal activity generates reactive oxygen species (ROS) and may have damaging effects on hepatocytes. Exercise is considered among the best treatments for NAFLD, but there is little molecular explanation for its benefits. We have developed a mitochondrial trifunctional protein (catalyzes last 3 steps in beta-oxidation) heterozygous mouse (MTPa) that develops NAFLD and insulin resistance due to impairment in mitochondrial fatty acid oxidation and accumulation of long chain fatty acid metabolites. The central hypothesis of this proposal is that daily exercise increases hepatic mitochondrial biogenesis in MTPa mice resulting in increased mitochondrial fatty acid oxidative capacity and reduced trafficking of fatty acids through peroxisomal pathways culminating in reduced hepatic-oxidative stress, -steatosis, and liver injury. We also postulate that this reduced hepatic oxidative stress will improve hepatic insulin signaling and whole body insulin sensitivity. MTP and MTP mice will either voluntarily exercise on running wheels or remain sedentary for 6 months. Measures of hepatic mitochondrial biogenesis and peroxisomal proliferation and fatty acid oxidative capacity will be assessed, along with hepatic lipid peroxidation and oxidative stress. MTP mice also will undergo hyperinsulinemic-euglycemic clamps to assess the influence of exercise on hepatic insulin signaling and whole-body insulin sensitivity. The long-term goal of this project is to explore mechanisms linked to reduced severity of hepatic steatosis with exercise training. PUBLIC HEALTH RELEVANCE: It also is estimated that more than 10 million Americans have disorders in mitochondrial fatty acid oxidation and 90 million US adults have NAFLD. Unfortunately, the effectiveness and biological mechanisms of current treatments are largely unknown. It is the focus of this project to identify potential mechanisms and therapeutic targets by which exercise can reduce the incidence of NAFLD by increasing hepatic mitochondrial function, reduce liver injury, and improve hepatic insulin sensitivity.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1155/2013/296537
发表时间:
2013
期刊:
Journal of obesity
影响因子:
3.3
作者:
[Perfield JW 2nd, Ortinau LC, Pickering RT, Ruebel ML, Meers GM, Rector RS]
通讯作者:
Rector RS
Hepatic eNOS and Mitochondrial Function in NASH
-
批准号:9346872
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2017
-
负责人:RANDY SCOTT RECTOR
-
依托单位:
Hepatic eNOS and Mitochondrial Function in NASH
-
批准号:9898232
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2017
-
负责人:RANDY SCOTT RECTOR
-
依托单位:
Hepatic Mitochondria and Insulin Resistance in Fatty Liver and Type 2 Diabetes
-
批准号:8244949
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:RANDY SCOTT RECTOR
-
依托单位:
Hepatic Mitochondria and Insulin Resistance in Fatty Liver and Type 2 Diabetes
-
批准号:8795676
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:RANDY SCOTT RECTOR
-
依托单位:
Hepatic Mitochondria and Insulin Resistance in Fatty Liver and Type 2 Diabetes
-
批准号:8402120
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:RANDY SCOTT RECTOR
-
依托单位:
Hepatic Mitochondria and Insulin Resistance in Fatty Liver and Type 2 Diabetes
-
批准号:8698282
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:RANDY SCOTT RECTOR
-
依托单位:
Hepatic Mitochondria and Insulin Resistance in Fatty Liver and Type 2 Diabetes
-
批准号:8141607
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:RANDY SCOTT RECTOR
-
依托单位:
Exercise, mitochondrial function, and fatty acid oxidation in fatty liver disease
-
批准号:7613590
-
项目类别:
-
资助金额:$4.68万
-
财政年份:2008
-
负责人:RANDY SCOTT RECTOR
-
依托单位:
海外基金